EvilHat & Biomihan
EvilHat EvilHat
Biomihan Biomihan
EvilHat EvilHat
Hey Biomihan, ever thought about designing a molecule that could hijack a cell’s own signaling just enough to push it into a new state? I’ve got a concept that could blow up the current research paradigm and, let’s face it, the funding would pour in if we play it right.
Biomihan Biomihan
That’s a bold hypothesis. Before we start synthesizing, we need a crystal‑clear model of the pathway you want to tweak and a reliable readout of the new state. Even a single off‑target effect could derail the whole project. If you can map out the binding kinetics and confirm that the molecule won’t just activate the pathway indiscriminately, we might be able to make a compelling case to the reviewers. It’s risky, but with rigorous validation, the payoff could be huge. What pathway are you thinking of targeting first?
EvilHat EvilHat
Let’s aim for the PI3K/AKT pathway—it's central, well‑charted, and a little tug on it can rewire growth and survival in a predictable way. We can design a ligand that nudges the receptor just enough to push AKT into a hyperactive yet controlled state, giving us that “new” phenotype without turning everything on. With a clear kinetic profile and a fluorescent reporter for AKT activity, we’ll have the hard evidence the reviewers love. And if the off‑target signal shows up, we tweak the ligand’s structure in one go—no wasted time. Sound good?
Biomihan Biomihan
It’s a sound outline, but the devil’s in the details. Make sure the ligand’s affinity and selectivity are quantified at single‑cell resolution, and plan a systematic off‑target screen before you commit to the first synthesis run. Otherwise you’ll end up chasing a phenotype that isn’t purely PI3K/AKT‑driven.
EvilHat EvilHat
Got it, I’ll set up a single‑cell binding assay and run a quick, broad off‑target panel so we can spot anything before we synthesize. That keeps the reviewers impressed and gives us the edge we need.
Biomihan Biomihan
Great, that’s the level of rigor we need. Keep the data clean and reproducible, and let me know the results so we can refine the design before any synthesis.
EvilHat EvilHat
Sure thing, I’ll keep the numbers tight and let you know the first round of data—just in case we need to tweak the design before the actual synthesis.
Biomihan Biomihan
Sounds like a plan. I’ll be on standby for the data. Once you have the numbers, we can decide if a structural tweak is necessary or if we’re ready to hit the synthesis bench.
EvilHat EvilHat
All right, I’ll keep the numbers pristine and have them to you before we lock in the next step—just remember, the best play is the one no one sees coming.